Imagining the future can shape the present: A systematic review of the impact of episodic future thinking on substance use outcomes.


Journal

Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors
ISSN: 1939-1501
Titre abrégé: Psychol Addict Behav
Pays: United States
ID NLM: 8802734

Informations de publication

Date de publication:
12 Jun 2023
Historique:
pmc-release: 12 12 2024
medline: 12 6 2023
pubmed: 12 6 2023
entrez: 12 6 2023
Statut: aheadofprint

Résumé

The combination of the high prevalence of problematic substance use and substance use disorders (SUD) with the low rates of spontaneous remission continues to generate interest in the development of novel and efficacious interventions. Theoretically, episodic future thinking (EFT) is capable of targeting various underlying psychological and neurobiological substrates of SUD by traversing various research domain criteria systems. The systematic review examines EFT as a potentially efficacious intervention for problematic substance use and SUD. The review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We examined 46 full-text studies (from 1,238 total records obtained from APA PsycInfo and Pubmed databases and reference list search), which yielded a final sample of 16 studies. The studies showed heterogeneity in their risk of bias, EFT protocols, and control conditions. Overall, EFT showed benefits in reducing self-reported or task-based substance use-related outcomes. Future research directions include establishing the feasibility of EFT, examining the generalizability in decreasing real-world substance use, identifying mediators and moderators of EFT outcomes, and determining the sustainability of EFT effects over time. EFT has high potential for dissemination. Limitations and potential for future research are discussed. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

Identifiants

pubmed: 37307365
pii: 2023-80188-001
doi: 10.1037/adb0000933
pmc: PMC10713863
mid: NIHMS1895724
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR002367
Pays : United States

Références

J Stud Alcohol Drugs. 2017 Jan;78(1):106-112
pubmed: 27936370
Q J Exp Psychol (Hove). 2022 Oct;75(10):1876-1891
pubmed: 34841982
Psychol Addict Behav. 2023 May;37(3):462-474
pubmed: 35482647
Drug Alcohol Depend. 2016 Nov 01;168:293-306
pubmed: 27614380
Addiction. 2006 Feb;101(2):212-22
pubmed: 16445550
J Subst Abuse Treat. 2020 Jun;113:108002
pubmed: 32359674
J Behav Med. 2018 Apr;41(2):269-276
pubmed: 29270887
Exp Clin Psychopharmacol. 2022 Dec;30(6):918-927
pubmed: 34096759
Int J Environ Res Public Health. 2021 Nov 30;18(23):
pubmed: 34886370
Ann N Y Acad Sci. 2008 Mar;1124:39-60
pubmed: 18400923
Addict Behav. 2019 Mar;90:222-228
pubmed: 30447514
Prev Med. 2020 Nov;140:106221
pubmed: 32717262
Hum Commun Res. 2019 Apr;45(2):148-168
pubmed: 30930526
J Stud Alcohol Drugs. 2009 Jul;70(4):516-27
pubmed: 19515291
Exp Clin Psychopharmacol. 2021 Feb;29(1):59-72
pubmed: 32191071
Exp Clin Psychopharmacol. 2018 Feb;26(1):94-107
pubmed: 29389172
Alcohol Clin Exp Res. 2016 Jul;40(7):1558-66
pubmed: 27246691
Psychopharmacology (Berl). 2022 Feb;239(2):631-642
pubmed: 35020047
Am Psychol. 1998 Apr;53(4):429-39
pubmed: 9572006
Cogn Dev. 2020 Oct-Dec;56:100934
pubmed: 32834469
Addiction. 2016 May;111(5):806-16
pubmed: 26616514
J Subst Abuse Treat. 2021 Apr;123:108259
pubmed: 33612193
Psychol Rev. 2004 Jan;111(1):33-51
pubmed: 14756584
Addiction. 2017 Jan;112(1):51-62
pubmed: 27450931
Exp Clin Psychopharmacol. 2008 Feb;16(1):57-65
pubmed: 18266552
Psychol Addict Behav. 2020 Jun;34(4):532-540
pubmed: 31999170
Drug Alcohol Depend. 2021 Aug 1;225:108795
pubmed: 34119880
Soc Work Public Health. 2013;28(3-4):165-74
pubmed: 23731411
Drug Alcohol Depend. 2019 Jan 1;194:136-142
pubmed: 30439610
JAMA Psychiatry. 2019 Nov 1;76(11):1176-1186
pubmed: 31461131
Cognition. 2020 Jun;199:104222
pubmed: 32092551
Addict Behav. 2016 Jul;58:74-9
pubmed: 26921721
Drug Alcohol Depend. 2015 Jul 1;152:32-8
pubmed: 26002377
Prev Med. 2019 Nov;128:105789
pubmed: 31400376
JAMA Psychiatry. 2016 Jan;73(1):39-47
pubmed: 26580136
Exp Clin Psychopharmacol. 2022 Jun;30(3):326-337
pubmed: 35041442
Exp Clin Psychopharmacol. 2022 Jun;30(3):313-325
pubmed: 33630649
Addiction. 2011 Mar;106(3):657-69
pubmed: 21077975
Addict Behav. 2017 Mar;66:1-6
pubmed: 27837662
J Exp Psychol Gen. 2016 Apr;145(4):402-18
pubmed: 26820166
Int J Environ Res Public Health. 2022 Jun 10;19(12):
pubmed: 35742385
Psychopharmacology (Berl). 2016 Oct;233(21-22):3771-3778
pubmed: 27553824
J Neurosci. 2011 May 4;31(18):6771-9
pubmed: 21543607
Psychol Med. 2021 Aug;51(11):1799-1806
pubmed: 34184631
J Subst Abuse Treat. 2020 Sep;116:108046
pubmed: 32741499
Conscious Cogn. 2017 May;51:10-16
pubmed: 28282631
PLoS One. 2019 Mar 28;14(3):e0214397
pubmed: 30921384
Curr Opin Behav Sci. 2017 Oct;17:41-50
pubmed: 29130061
JAMA Psychiatry. 2015 Aug;72(8):757-66
pubmed: 26039070
Neuron. 2010 Apr 15;66(1):138-48
pubmed: 20399735

Auteurs

Anahi Collado (A)

Renee Crown Wellness Institute, University of Colorado-Boulder.

Alexis Stokes (A)

Alvord, Baker and Associates, LLC.

Classifications MeSH